@article{dd39bfee69d14f2eab9defa8a5184063,
title = "Duration of long-acting injectable antipsychotic treatment and reasons for its discontinuation: A chart review of patients with schizophrenia",
author = "Taro Kishi and Kenji Sakuma and Makoto Okuya and Masakazu Hatano and Nakao Iwata",
note = "Funding Information: Drs. Kishi, Sakuma, Okuya, Hatano, and Iwata declare that they have no direct conflicts of interest relevant to this study. Dr. Kishi received speaker's honoraria from Daiichi Sankyo, Dainippon Sumitomo, Eisai, Janssen, Otsuka, Meiji, Mochida, MSD, and Tanabe‐Mitsubishi (Yoshitomi), as well as research grants from the Japanese Ministry of Health, Labour, and Welfare, a Grant‐in‐Aid for Scientific Research (C) (19K08082), and Fujita Health University School of Medicine. This work was supported by a Grant‐in‐Aid for Scientific Research (C) (19K08082). This funding source had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results. Dr. Sakuma has received speaker's honoraria from Eisai, Kissei, Meiji, Otsuka, and Torii and has received a Fujita Health University School of Medicine research grant, as well as a Grant‐in‐Aid for Young Scientists (B). Dr. Okuya has received speaker's honoraria from Meiji. Dr. Hatano has received speaker's honoraria from Dainippon Sumitomo and Otsuka. Dr. Iwata received speaker's honoraria from Dainippon Sumitomo, Eli Lilly, GlaxoSmithKline, Janssen, Yoshitomi, Otsuka, Takeda, Meiji, and Pfizer, along with research grants from Daiichi Sankyo, Takeda, Dainippon Sumitomo Eisai, Meiji, Tanabe‐Mitsubishi, and Otsuka. Funding Information: We thank all the participants of this study, which was supported by a Grant‐in‐Aid for Scientific Research (C) (19K08082). ",
year = "2021",
month = jul,
doi = "10.1111/pcn.13222",
language = "English",
volume = "75",
pages = "240--241",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "7",
}
SDG 3 すべての人に健康と福祉を